Bobby Sheng

Bobby Sheng is the Chairman and CEO of Bora Pharmaceuticals, the preeminent pharmaceutical manufacturing company in Taiwan. Under his visionary leadership, Bora Pharmaceuticals has established itself as a formidable force in the industry, renowned for its innovative and efficient healthcare solutions. The company, a paragon of excellence listed on the Taiwan Stock Exchange, operates globally with ten manufacturing sites in Taiwan and North America.

Raised in Southern California, Sheng's academic journey began at the University of California, Berkeley, setting the stage for a career marked by unparalleled entrepreneurial success. Since establishing Bora, Sheng has been the driving force behind a remarkable 7000% increase in the company's market capitalization since IPO. This extraordinary growth underscores his strategic prowess and his ability to navigate the complexities of the pharmaceutical industry.

Born Pharmaceuticals' business model, which includes Contract Development and Manufacturing Organization (CDMO) and Commercial Rx operations, has garnered acclaim for its rapid mergers and acquisitions and its culture of excellence. Under Sheng's leadership, the company has received numerous prestigious awards, including "Most Outstanding Company of the Year" and the Presidential Award for "The Most Innovative Company of the Year" in 2024.

Beyond his business accomplishments, Sheng is also noted for his philanthropic efforts, significantly contributing to various causes and demonstrating a profound commitment to societal well-being. Bobby Sheng's extraordinary leadership and philanthropy are not only transforming Bora Pharmaceuticals but also making a significant impact on the global healthcare landscape.